chr2-73426482-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001378454.1(ALMS1):​c.1267G>A​(p.Val423Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00388 in 1,614,050 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0040 ( 24 hom. )

Consequence

ALMS1
NM_001378454.1 missense

Scores

16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: -0.251
Variant links:
Genes affected
ALMS1 (HGNC:428): (ALMS1 centrosome and basal body associated protein) This gene encodes a protein containing a large tandem-repeat domain as well as additional low complexity regions. The encoded protein functions in microtubule organization, particularly in the formation and maintanance of cilia. Mutations in this gene cause Alstrom syndrome. There is a pseudogene for this gene located adjacent in the same region of chromosome 2. Alternative splice variants have been described but their full length nature has not been determined. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004122615).
BP6
Variant 2-73426482-G-A is Benign according to our data. Variant chr2-73426482-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 240983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0029 (441/152280) while in subpopulation SAS AF= 0.00643 (31/4824). AF 95% confidence interval is 0.00465. There are 1 homozygotes in gnomad4. There are 205 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ALMS1NM_001378454.1 linkuse as main transcriptc.1267G>A p.Val423Ile missense_variant 6/23 ENST00000613296.6 NP_001365383.1
ALMS1NM_015120.4 linkuse as main transcriptc.1270G>A p.Val424Ile missense_variant 6/23 NP_055935.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ALMS1ENST00000613296.6 linkuse as main transcriptc.1267G>A p.Val423Ile missense_variant 6/231 NM_001378454.1 ENSP00000482968 P3Q8TCU4-1

Frequencies

GnomAD3 genomes
AF:
0.00290
AC:
441
AN:
152162
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.00368
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00469
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00290
AC:
722
AN:
249394
Hom.:
7
AF XY:
0.00312
AC XY:
422
AN XY:
135292
show subpopulations
Gnomad AFR exome
AF:
0.000969
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.000894
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00523
Gnomad FIN exome
AF:
0.00357
Gnomad NFE exome
AF:
0.00387
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00398
AC:
5821
AN:
1461770
Hom.:
24
Cov.:
31
AF XY:
0.00400
AC XY:
2907
AN XY:
727192
show subpopulations
Gnomad4 AFR exome
AF:
0.000747
Gnomad4 AMR exome
AF:
0.000402
Gnomad4 ASJ exome
AF:
0.000918
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00538
Gnomad4 FIN exome
AF:
0.00283
Gnomad4 NFE exome
AF:
0.00442
Gnomad4 OTH exome
AF:
0.00349
GnomAD4 genome
AF:
0.00290
AC:
441
AN:
152280
Hom.:
1
Cov.:
32
AF XY:
0.00275
AC XY:
205
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.000842
Gnomad4 AMR
AF:
0.000720
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00643
Gnomad4 FIN
AF:
0.00368
Gnomad4 NFE
AF:
0.00469
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00401
Hom.:
3
Bravo
AF:
0.00257
TwinsUK
AF:
0.00620
AC:
23
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00129
AC:
5
ESP6500EA
AF:
0.00423
AC:
35
ExAC
AF:
0.00258
AC:
312
Asia WGS
AF:
0.00404
AC:
15
AN:
3478
EpiCase
AF:
0.00403
EpiControl
AF:
0.00356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:7
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 12, 2016- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsSep 20, 2018- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxNov 30, 2020This variant is associated with the following publications: (PMID: 28717663, 25846608, 18154657, 21157496, 25296579) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024ALMS1: BP4, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:4
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 21, 2016p.Val423Ile in exon 6 of ALMS1: This variant is not expected to have clinical si gnificance because it has been identified in 0.50% (82/16512) of South Asian chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs45630557). -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 21, 2018Variant summary: ALMS1 c.1267G>A (p.Val423Ile, alternative name c.1270G>A) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0028 in 276990 control chromosomes, predominantly found within the South Asian subpopulation with a frequency of 0.0051 in the gnomAD database, including 4 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 2.3 fold of the estimated maximal expected allele frequency for a pathogenic variant in ALMS1 causing Cardiomyopathy phenotype (0.0022), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. At least one publication reports experimental evidence, demonstrating no sign of exon skipping with normal ALMS1 expression and without discernible defects in ciliary morphology in a cell line established from an individual carrying the variant (Chen 2017). These results indicate no damaging effect for this variant. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoDec 30, 2016- -
Alstrom syndrome Benign:2
Benign, no assertion criteria providedclinical testingNatera, Inc.Dec 02, 2019- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Monogenic diabetes Benign:1
Likely benign, criteria provided, single submitterresearchPersonalized Diabetes Medicine Program, University of Maryland School of MedicineMar 31, 2017ACMG criteria: BP4 (9 predictors), BP1 (missense when truncating cause disease)=likely benign -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 02, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
0.018
DANN
Benign
0.72
DEOGEN2
Benign
0.014
T;T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0049
N
LIST_S2
Benign
0.57
T;T;T
M_CAP
Benign
0.0035
T
MetaRNN
Benign
0.0041
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.55
.;N;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.25
T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.080
MVP
0.17
ClinPred
0.0014
T
GERP RS
0.20
Varity_R
0.010
gMVP
0.0070

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45630557; hg19: chr2-73653610; COSMIC: COSV52525837; API